Description: This document is a Request for Proposals (RFP) outlining a proposal request on the impact of the U.S. drug abuse epidemic on mortality, focusing on opioids. It provides details on the background, purpose, research objectives, proposal requirements, selection process, and conditions for submitting a proposal.

Description: 2024 Financial Reporting Section Research Ideas Contest.

Description: The Actuarial Research Clearing House (ARCH) is an informal communication providing current actuarial research to friends and members of the actuarial community. View the second issue for 2024.

Description: The SOA ImpACT Conference is the premier gathering of industry experts, employers, actuarial professionals, and thought-leaders. Save the date for the 2029 ImpACT Conference.

Description: This data request is for a study focusing on surrender/lapse, withdrawal, living benefit utilization, annuitization, and premium deposit experiences. The study aims to provide detailed analysis and insights into fixed indexed annuity contract activities.

Description: We explore the question of how an actuary–artificial intelligence collaboration might look in the future and how actuaries should be trained to best leverage this technology. It felt fitting to accomplish this through a conversation with an AI system, as AI involvement is warranted to ground the analysis in the technology’s true capabilities.

Description: This article takes a look at how defined benefit (DB) pension plan financials ended the third quarter of 2023 on a solid footing, improving the capacity to take meaningful de-risking actions; as DB plans look to de-risk at reasonable costs, they may find it beneficial to consider a broad range of investment options; and completing a core bond allocation with private credit and income-oriented alternative strategies can help achieve important savings over other frequently pursued de-risking approaches, without materially increasing the funded status volatility or downside risk

Description: This article attempts to make a modest contribution to the dialogue on the potential and risks associated with novel treatments such as cell & gene therapies. With a fast-expanding roster of what are believed to be one-time treatments at ever increasing price points aimed at curing a wider swatch of the population, they are as much a source of relief for patients stuck in medical limbo, as they are a source of anxiety for payers.

Description: The global nature of the reinsurance industry has enabled the diversification of risk away from concentration in specific regions to the larger global market. However, record catastrophe losses, inflation stemming from increased interest rates, geopolitical tensions and heightened climate risk are putting operating pressures on insurers and reinsurers. Article discusses the implications.